Literature DB >> 7595226

T cells, but not B cells, are required for bowel inflammation in interleukin 2-deficient mice.

A Ma1, M Datta, E Margosian, J Chen, I Horak.   

Abstract

Interleukin-2 (IL-2)-deficient (IL-2-/-) mice develop anemia and colonic inflammatory bowel disease. To elucidate the mechanism of this disease, we have bred IL-2-/- mice to two strains of immunodeficient mice, RAG-2-deficient (RAG-2-/-, lacking B and T cells) and JH-deficient mice (JH-/-, lacking B cells). IL-2-/-, RAG-2-/- double-mutant mice are disease free, while IL-2-/-, JH-/- double-mutant mice succumb to bowel disease at the same rate as IL-2-/- littermates. IL-2-/-, JH-/- mice do not, however, succumb to anemia. Thus, spontaneous intestinal inflammation in IL-2-/- mice requires mature T cells, not B cells, while anemia is dependent on B cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7595226      PMCID: PMC2192197          DOI: 10.1084/jem.182.5.1567

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  A new surface antigen on intraepithelial lymphocytes in the intestine.

Authors:  P J Kilshaw; S J Murant
Journal:  Eur J Immunol       Date:  1990-10       Impact factor: 5.532

2.  RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement.

Authors:  Y Shinkai; G Rathbun; K P Lam; E M Oltz; V Stewart; M Mendelsohn; J Charron; M Datta; F Young; A M Stall
Journal:  Cell       Date:  1992-03-06       Impact factor: 41.582

3.  Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice.

Authors:  P Mombaerts; E Mizoguchi; M J Grusby; L H Glimcher; A K Bhan; S Tonegawa
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

4.  Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene.

Authors:  B Sadlack; H Merz; H Schorle; A Schimpl; A C Feller; I Horak
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

5.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

6.  Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain.

Authors:  X Cao; E W Shores; J Hu-Li; M R Anver; B L Kelsall; S M Russell; J Drago; M Noguchi; A Grinberg; E T Bloom
Journal:  Immunity       Date:  1995-03       Impact factor: 31.745

7.  Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice.

Authors:  L A Dieleman; B U Ridwan; G S Tennyson; K W Beagley; R P Bucy; C O Elson
Journal:  Gastroenterology       Date:  1994-12       Impact factor: 22.682

8.  Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice.

Authors:  F Powrie; M W Leach; S Mauze; L B Caddle; R L Coffman
Journal:  Int Immunol       Date:  1993-11       Impact factor: 4.823

9.  Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting.

Authors:  H Schorle; T Holtschke; T Hünig; A Schimpl; I Horak
Journal:  Nature       Date:  1991-08-15       Impact factor: 49.962

10.  The role of B cells in lpr/lpr-induced autoimmunity.

Authors:  M J Shlomchik; M P Madaio; D Ni; M Trounstein; D Huszar
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

View more
  18 in total

Review 1.  Clinical aspects and pathophysiology of inflammatory bowel disease.

Authors:  Barbara A Hendrickson; Ranjana Gokhale; Judy H Cho
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

2.  Characterization of the mucosal cell-mediated immune response in IL-2 knockout mice before and after the onset of colitis.

Authors:  S A McDonald; M J Palmen; E P Van Rees; T T MacDonald
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

3.  Endogenous antigen presenting cell-derived IL-10 inhibits T lymphocyte responses to commensal enteric bacteria.

Authors:  Carol A Albright; R Balfour Sartor; Susan L Tonkonogy
Journal:  Immunol Lett       Date:  2009-03-03       Impact factor: 3.685

Review 4.  Immunopathology of human inflammatory bowel disease.

Authors:  P Brandtzaeg; G Haraldsen; J Rugtveit
Journal:  Springer Semin Immunopathol       Date:  1997

5.  Inflammation-induced Occludin Downregulation Limits Epithelial Apoptosis by Suppressing Caspase-3 Expression.

Authors:  Wei-Ting Kuo; Le Shen; Li Zuo; Nitesh Shashikanth; Ma Lora Drizella M Ong; Licheng Wu; Juanmin Zha; Karen L Edelblum; Yitang Wang; Yingmin Wang; Steven P Nilsen; Jerrold R Turner
Journal:  Gastroenterology       Date:  2019-08-08       Impact factor: 22.682

6.  Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation.

Authors:  I B Autenrieth; N Bucheler; E Bohn; G Heinze; I Horak
Journal:  Gut       Date:  1997-12       Impact factor: 23.059

7.  Disrupted B-lymphocyte development and survival in interleukin-2-deficient mice.

Authors:  M Schultz; S H Clarke; L W Arnold; R B Sartor; S L Tonkonogy
Journal:  Immunology       Date:  2001-10       Impact factor: 7.397

8.  Reduced susceptibility to dextran sulphate sodium-induced colitis in the interleukin-2 heterozygous (IL-2) mouse.

Authors:  Malin Sund; Li Li Xu; Arman Rahman; Bi-Feng Qian; Marie-Louise Hammarström; Ake Danielsson
Journal:  Immunology       Date:  2005-04       Impact factor: 7.397

Review 9.  Genetically engineered mouse models for studying inflammatory bowel disease.

Authors:  Atsushi Mizoguchi; Takahito Takeuchi; Hidetomo Himuro; Toshiyuki Okada; Emiko Mizoguchi
Journal:  J Pathol       Date:  2015-11-14       Impact factor: 7.996

10.  Impaired autophagy, defective T cell homeostasis, and a wasting syndrome in mice with a T cell-specific deletion of Vps34.

Authors:  Vrajesh V Parekh; Lan Wu; Kelli L Boyd; Janice A Williams; Jennifer A Gaddy; Danyvid Olivares-Villagómez; Timothy L Cover; Wei-Xing Zong; Jianhua Zhang; Luc Van Kaer
Journal:  J Immunol       Date:  2013-04-17       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.